MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation

Lei Huang; Xiaodong Liao; Michael Beckett; Yuan Li; Kum Kum Khanna; Zhugang Wang; Surender Kharbanda; Ralph Weichselbaum; Donald Kufe

doi:10.1177/1947601910368059

. 2010 Mar;1(3):239–250. doi: 10.1177/1947601910368059

MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation

Lei Huang ^1,², Xiaodong Liao ¹, Michael Beckett ³, Yuan Li ¹, Kum Kum Khanna ⁴, Zhugang Wang ¹, Surender Kharbanda ², Ralph Weichselbaum ³, Donald Kufe ^2,^✉

PMCID: PMC2943399 NIHMSID: NIHMS228156 PMID: 20865059

Abstract

The ataxia-telangiectasia mutated (ATM) kinase is activated in the cellular response to ionizing radiation (IR) and is of importance to the repair of DNA double-strand breaks (DSBs). The MUC1 oncoprotein is aberrantly overexpressed in human breast carcinomas. The present work demonstrates that the MUC1 C-terminal subunit (MUC1-C) constitutively interacts with ATM in human breast cancer cells. The authors show that the MUC1-C cytoplasmic domain binds directly to ATM HEAT repeats. The results also demonstrate that the MUC1-C cytoplasmic domain binds to the ATM substrate H2AX. The functional significance of these interactions is supported by the finding that MUC1-C promotes removal of IR-induced nuclear γH2AX foci. MUC1-C also protects against IR-induced chromosomal aberrations. In concert with these results, MUC1-C blocks IR-induced death by promoting repair of potentially lethal DNA damage. These findings indicate that the overexpression of MUC1 can protect against IR-induced DNA DSBs and may represent a physiologic response that has been exploited by malignant cells.

Keywords: MUC1, ATM, DNA damage, H2AX, ionizing radiation

Introduction

The ataxia telangiectasia mutated (ATM) kinase is activated in the cellular response to ionizing radiation (IR). Mutation of ATM is associated with genomic instability, increased sensitivity to IR, and cell cycle defects in the response to DNA damage.¹ ATM phosphorylates diverse targets, such as H2AX, NBS1, and Chk1, that activate cell cycle checkpoints and DNA repair.² The phosphorylation of H2AX (γH2AX) is an early ATM-mediated response to DNA double-strand breaks (DSBs).^3-5 In turn, γH2AX interacts with NBS1 to form nuclear foci at sites of DNA damage.⁶ The interaction between γH2AX and NBS1 then further contributes to recruitment of MRE11 and RAD50 from the cytoplasm to DNA DSB sites.^6,7 In this regard, loss of H2AX is associated with defects in DSB repair and genomic instability due to decreased formation of nuclear foci.^8,9 Activation of ATM and its recruitment to DNA DSBs also involves interaction with NBS1.¹⁰ The HEAT repeats in ATM bind directly to the NBS1 C-terminal FXF/Y domain, and this interaction is essential for ATM activation.¹⁰ In turn, the MRE11-RAD50-NBS1 (MRN) complex functions in ATM-mediated checkpoint responses and cell survival.^11-14 Early phosphorylation of H2AX is of importance to the formation of the MRN complex and to induction of cell cycle arrest and DNA repair.³ The kinetics of H2AX phosphorylation also reflect the rate of DSB repair and resolution of the DNA damage response.^3,15

Mucin 1 (MUC1) is a heterodimeric transmembrane protein that is aberrantly overexpressed in diverse human carcinomas.^16,17 The MUC1 C-terminal subunit (MUC1-C) consists of a 58–amino acid extracellular domain, a 28–amino acid transmembrane domain, and a 72–amino acid cytoplasmic tail.^17,18 Galectin-3 interacts with the MUC1-C extracellular domain and promotes the formation of MUC1-C complexes with growth factor receptors.¹⁹ The MUC1-C cytoplasmic domain is phosphorylated by c-Src,²⁰ protein kinase C,²¹ glycogen synthase kinase 3β,²² and c-Abl.²³ Moreover, the MUC1-C cytoplasmic domain interacts with effectors, such as β-catenin,^24,25 IκB kinase,²⁶ and p53,²⁷ which have been linked to the regulation of cell growth and death. Overexpression of MUC1 results in the accumulation of MUC1-C in the cytoplasm and targeting of this subunit to the nucleus^27-30 and mitochondria.^31,32 Importantly, expression of the MUC1-C cytoplasmic domain is sufficient to induce transformation²⁴ and activate expression of gene signatures associated with poor outcomes in patients with breast cancer.^33,34 Other studies have demonstrated that MUC1-C confers resistance to apoptosis or necrosis in the response of cells to (1) DNA damage induced by chemotherapeutic agents,^31,35 (2) reactive oxygen species (ROS)–induced stress,^36,37 and (3) hypoxia.³⁸ IR activates diverse forms of ROS, among which hydroxyl radicals contribute to the formation of DSBs. However, it is not known if MUC1 affects the response to IR treatment.

The present results demonstrate that MUC1-C associates with ATM and that the MUC1-C cytoplasmic domain binds directly to the ATM HEAT repeat region. The results also demonstrate that MUC1-C interacts with H2AX, promotes removal of IR-induced γH2AX foci, and protects against IR-induced cell death.

Results

MUC1-C associates with ATM

To investigate the potential interaction between MUC1 and the DNA damage response, we first studied the interaction between MUC1-C and ATM in human ZR-75-1 breast cancer cells that overexpress endogenous MUC1. Immunoblot analysis of anti-MUC1-C precipitates with anti-ATM demonstrated that MUC1-C associates with ATM (Fig. 1A, left). These results were confirmed in the reciprocal experiment by immunoblotting anti-ATM precipitates with anti-MUC1-C (Fig. 1A, right). The coprecipitation of MUC1-C and ATM was also obtained in studies of MCF-7 breast cancer cells (Fig. 1B). In addition, transient transfection of 293 cells with a Flag-tagged ATM and MUC1 confirmed that MUC1-C associates with ATM in reciprocal immunoprecipitation experiments (Fig. 1C). To determine whether the MUC1-C cytoplasmic domain (MUC1-CD) confers the association, we expressed green fluorescent protein (GFP)–tagged MUC1-CD in 293 cells. Immunoblot analysis of anti-ATM precipitates with anti-GFP further demonstrated that MUC1-CD forms complexes with ATM (Fig. 1D). These findings indicated that MUC1-C associates with ATM and that the interaction is conferred through the MUC1-C cytoplasmic domain.

Figure 1. — MUC1-C associates with ataxia-telangiectasia mutated (ATM) kinase. (A) Lysates from ZR-75-1 cells were immunoprecipitated with a control IgG, anti-MUC1-C (**left**), or anti-ATM (**right**). The precipitates were immunoblotted with the indicated antibodies. (B) Control IgG and anti-ATM precipitates from MCF-7 cell lysates were immunoblotted with the indicated antibodies. (C) 293 cells were cotransfected with Flag-tagged ATM and MUC1. After 36 h, lysates were immunoprecipitated with a control IgG, anti-MUC1-C (**left**), or anti-Flag (**right**). The precipitates were immunoblotted with the indicated antibodies. (D) 293 cells were transfected with green fluorescent protein (GFP) or GFP-MUC1-CD for 36 h. Anti-ATM precipitates were immunoblotted with the indicated antibodies (**upper 2 panels**). Lysates not subjected to precipitation were immunoblotted with anti-GFP (**lower panel**).

MUC1-CD binds directly to ATM

To define the region of ATM responsible for the interaction with MUC1-C, we purified glutathione S-transferase (GST) fusion proteins containing fragments of ATM (Fig. 2A).³⁹ Incubation of the GST and the GST-ATM proteins with lysates from 293 cells expressing GFP-MUC1-CD demonstrated binding of MUC1-CD to ATM(1439-1770), ATM(1764-2138), ATM (2141-2428), and ATM(2842-3056) (Fig. 2B). To determine whether the interaction is direct, we incubated the GST-ATM proteins with purified His-tagged MUC1-CD. The results demonstrate that MUC1-CD binds directly to ATM(1439-1770) and not the other fragments (Fig. 2C). Experiments with deletion mutants of MUC1-CD further demonstrated that the N-terminal region (amino acids 1-5; CQCRR) is sufficient for binding to ATM(1439-1770) (Fig. 2D). These findings demonstrate that MUC1-CD binds directly with the HEAT repeat region of ATM.

Figure 2. — MUC1-CD binds directly to ataxia-telangiectasia mutated (ATM) kinase. (A) Schematic representation of ATM structure and expression of the glutathione S-transferase (GST)–ATM fusion proteins. (B) Lysates from 293 cells expressing green fluorescent protein (GFP)–MUC1-CD were incubated with GST and the indicated GST-ATM fusion proteins. The adsorbates were immunoblotted with anti-GFP. (C) GST and the indicated GST-ATM fusion proteins linked to glutathione beads were incubated with purified His-MUC1-CD. The adsorbates were immunoblotted with anti-MUC1-C. (D) Amino acid sequence of MUC1-CD (**upper panel**). Lysates from 293 cells expressing GFP or the indicated GFP-MUC1-CD fusion proteins were incubated with GST-ATM(1439-1770). The adsorbates were immunoblotted with anti-GFP. Expression of the GFP proteins was assessed by immunoblot analysis of lysates with anti-GFP (**lower panel**).

MUC1-C CQC motif is responsible for interactions with ATM and H2AX

To more precisely define the MUC1-CD amino acids responsible for the interaction, we mutated Cys-1 to Ala (C1A) and Cys-3 to Ala (C3A). Binding of the MUC1-CD(C1A) mutant to ATM(1439-1770) was somewhat increased compared to that obtained with MUC1-CD (Fig. 3A). Moreover, the association with ATM(1439-1770) was decreased with MUC1-CD(C3A) and abrogated with the double MUC1-CD(C1A/C3A) mutant (Fig. 3A). Mutation of both Cys-1 and Cys-3 also abrogated the association of MUC1-CD with ATM(1764-2138), ATM(2141-2428), and ATM(2842-3056) (Fig. 3B). These results indicated that MUC1-CD amino acids Cys-1/Cys-3 confer direct binding to ATM(1439-1770) and that MUC1-CD associates indirectly with ATM(1764-2138), ATM(2141-2428), and ATM(2842-3056) in cells. ATM phosphorylates H2AX on Ser-139 in the response to DNA damage.^3,40 To determine whether MUC1-C also associates with H2AX, lysates from 293 cells expressing GFP or GFP-MUC1-CD were incubated with GST-H2AX. Immunoblot analysis of the adsorbates demonstrated that H2AX associates with MUC1-CD (Fig. 3C). In addition, incubation of GST-H2AX with lysates of 293 cells expressing GFP-MUC1-CD mutants demonstrated that H2AX interacts with MUC1-CD(1-45) but not MUC1-CD(46-72) or MUC1-CD(C1A/C3A) (Fig. 3C). Incubation of GST-H2AX with His-MUC1-CD further demonstrated a direct interaction between MUC1-CD and H2AX (Fig. 3D). These findings indicate that MUC1-C associates with ATM and H2AX.

Figure 3. — MUC1-C associates with the ataxia-telangiectasia mutated (ATM)–H2AX complex. (A) Lysates from 293 cells expressing green fluorescent protein (GFP), GFP-MUC1-CD, GFP-MUC1-CD(C1A), GFP-MUC1-CD(C3A), or GFP-MUC1-CD(C1A/C3A) were incubated with glutathione S-transferase (GST)–ATM(1439-1770). The adsorbates were immunoblotted with anti-GFP (**upper panel**) and anti-GST (**middle panel**). Lysates were also immunoblotted with anti-GFP (**lower panel**). (B) Lysates from 293 cells expressing GFP or the indicated GFP-MUC1-CD fusion proteins were incubated with GST-ATM(1764-2138), GST-ATM(2141-2428), or GST-ATM(2842-3056). Adsorbates were immunoblotted with anti-GFP. Lysates were also immunoblotted with anti-GFP (**lower panel**). (C) Lysates from 293 cells expressing GFP or the indicated GFP-MUC1-CD fusion proteins were incubated with GST-H2AX. Adsorbates were immunoblotted with anti-GFP (**upper panel**) and anti-GST (**middle panel**). Lysates were also immunoblotted with anti-GFP (**lower panel**). (D) GST and GST-H2AX linked to glutathione beads were incubated with purified His-MUC1-CD. The adsorbates were immunoblotted with anti-MUC1-C (**upper panel**). Input of GST-H2AX and His-MUC1-CD was determined by immunoblotting with anti-GST and anti-MUC1-C, respectively (**lower 2 panels**).

MUC1 regulates ATM-mediated phosphorylation of H2AX

To assess whether MUC1 affects H2AX phosphorylation, we irradiated ZR-75-1 cells stably expressing an empty vector or a MUC1siRNA.^27,30,31 Notably, analysis of lysates from 2 ZR-75-1/MUC1siRNA cell clones exposed to 2.5 and 5.0 Gy IR demonstrated that silencing MUC1 is associated with increases in intensity of H2AX phosphorylation (Fig. 4A). ATM-mediated phosphorylation of H2AX is associated with activation of cell cycle checkpoints.^2,40,41 To determine whether MUC1 also affects checkpoint activation, we studied cell cycle distribution in the response to IR treatment. Silencing MUC1 in ZR-75-1 cells was associated with a marked increase in accumulation of S phase cells as compared to that in ZR-75-1/vector cells expressing endogenous MUC1 (Fig. 4B). In concert with these results, silencing MUC1 in ZR-75-1 cells increased the IR-induced arrest in G2-M phase as determined by phospho-histone H3 staining (Fig. 4C). To extend the analysis of MUC1 in the IR response, the ZR-75-1/MUC1siRNA cells were transfected with an empty vector or one expressing Flag-MUC1-CD (Fig. 4D). MUC1-CD suppressed the induction of γH2AX in response to 2.5 and 10 Gy IR (Fig. 4D). By contrast, this suppression of IR-induced γH2AX was attenuated by expression of the MUC1-CD(C1A/C3A) mutant that fails to associate with ATM and H2AX (Fig. 4D). These findings provided support for involvement of MUC1 in the regulation of IR-induced H2AX phosphorylation.

Figure 4. — Silencing MUC1 is associated with increased levels of γH2AX in the response to ionizing radiation (IR). (A) The indicated ZR-75-1 cells were left untreated or treated with 2.5 or 5.0 Gy IR and incubated for 1 h. Lysates were immunoblotted with the indicated antibodies. (B) ZR-75-1/vector and ZR-75-1/MUC1siRNA cells were treated with 10 Gy IR and harvested after incubation for 12 h. Cells were fixed, incubated with PI, and analyzed for cell cycle distribution. (C) ZR-75-1/vector (open squares) and ZR-75-1/MUC1siRNA (solid squares) cells were treated with the indicated doses of IR, incubated for 1 h, and analyzed for reactivity with anti-phospho-H3. The results are expressed as the relative number of phospho-H3-positive cells (mean ± SD of 3 experiments) after IR treatment compared to that obtained with unirradiated cells. (D) ZR-75-1/MUC1siRNA cells were transfected to express an empty vector, Flag-MUC1-CD, or Flag-MUC1-CD(C1A/C3A). The cells were left untreated or treated with 2.5 or 10 Gy IR and incubated for 1 h. Lysates were immunoblotted with the indicated antibodies.

MUC1 promotes removal of γH2AX foci and attenuates loss of clonogenic survival

Phosphorylated H2AX accumulates at sites of DSBs.⁴⁰ γH2AX foci were detectable in the nuclei of irradiated ZR-75-1/vector cells (Fig. 5A). However, this response was decreased compared to that in irradiated ZR-75-1/MUC1siRNA cells (Fig. 5A). ATM-mediated phosphorylation of H2AX is also associated with activation of DNA repair.^2,40,41 In this regard, IR-induced γH2AX readily disappeared in ZR-75-1/vector cells as compared to the prolonged detection of γH2AX in ZR-75-1/MUC1siRNA cells (Fig. 5B). In concert with these results, analysis of γH2AX foci/cell over time demonstrated that MUC1 is associated with increased removal of γH2AX foci (Fig. 5C). To assess the effects of MUC1 on survival following IR treatment, we irradiated ZR-75-1 cells with 2 to 8 Gy. After 24 h, the cells were replated and assessed for colony formation at 3 weeks. IR treatment of ZR-75-1/vector cells had a partial effect on survival (Fig. 5D). By contrast, irradiation of the 2 ZR-75-1/MUC1siRNA clones was associated with substantial decreases in survival at doses of 2 and 4 Gy and the absence of colonies with treatment at 6 and 8 Gy IR (Fig. 5D). Analysis of chromosomes from the irradiated ZR-75-1 cells further demonstrated that silencing MUC1 is associated with an increase in aberrations, specifically chromatid breaks, double minutes, and fissions (Table 1). These findings collectively indicated that MUC1 promotes the rate of DNA DSB repair.

Figure 5. — MUC1 promotes removal of ionizing radiation (IR)–induced γH2AX foci arrest and attenuates loss of survival. (A) The indicated ZR-75-1 cells were left untreated or treated with 5 Gy IR and incubated for 1 h before staining for γH2AX (red). Nuclei were stained with 4′-6-diamidino-2-phenylindole (DAPI; blue) and the images merged. (B) The indicated ZR-75-1 cells were treated with 10 Gy IR and harvested at the indicated times. Lysates were immunoblotted with the indicated antibodies. (C) ZR-75-1/vector (solid bars) and ZR-75-1/MUC1siRNA (open bars) cells were treated with 1 Gy IR, incubated for the indicated times, and stained with anti-γH2AX. γH2AX foci were counted for at least 30 cells at each time point. The results are expressed as the relative number (mean ± SD) of γH2AX foci/cell remaining compared to that obtained at 0.25 h. (D) ZR-75-1/vector (open squares), ZR-75-1/MUC1siRNA-A (closed squares), and ZR-75-1/MUCsiRNA-B (closed triangles) were treated with the indicated IR doses. After 24 h, the cells were replated and cultured for 2 to 3 weeks. The colonies were stained with crystal violet and counted manually. The results are expressed as the colony number (mean ± SD of 3 determinations) as compared to that for nonirradiated control cells. Plating efficiency for the ZR-75-1/vector, ZR-75-1/MUC1siRNA-A, and ZR-75-1/MUC1siRNA-B cells was 0.11, 0.15 and 0.13, respectively.

Table 1.

Chromosome Aberrations in Ionizing Radiation (IR)–Treated ZR-75-1/Vector and ZR-75-1/MUC1siRNA-A Cells

	ZR-75-1/CsiRNA		ZR-75-1/MUC1siRNA-A
Aberrations	IR−	IR+	IR−	IR+
Chromosome breaks	0	0	0	0
Chromatid breaks	0	2	0	21
Triradial (tr) and quadriradial	0	3	0	5
Complex radial	0	1	0	0
Dicentric chromosomes	0	0	0	1
Tricentric chromosomes	0	0	0	0
Ring chromosomes	0	0	0	1
Double minutes	12	28	8	60
Acentric fragments	0	19	1	15
Telomeric association (of acrocentric chromosomes)	0	2	0	3
Fission (centrometric, longitudinal)	0	12	10	71
Total # aberrations	12	67	19	177

Open in a new tab

MUC1-CD is sufficient for promoting removal of IR-induced γH2AX foci

To determine whether MUC1-CD is sufficient for regulating H2AX phosphorylation, we studied rat 3Y1 fibroblasts that stably express an empty vector or MUC1-CD.²⁴ The results show that MUC1-CD attenuates H2AX phosphorylation in the response of 3Y1 cells to 2.5 and 10 Gy IR (Fig. 6A). Analysis of γH2AX foci/cell over time further demonstrated that MUC1-CD promotes removal of γH2AX foci (Fig. 6B). Moreover, expression of MUC1-CD in 3Y1 cells decreased the IR-induced arrest in G2-M phase as determined by phospho-histone H3 staining (Fig. 6C). To extend these results, the 3Y1 cells were treated with 7 Gy IR and then replated at different intervals after irradiation. The highest surviving fraction for the 3Y1/vector cells was at 4 h (Fig. 6D). Moreover, the highest surviving fraction for the two 3Y1/MUC1-CD clones was 24 h (Fig. 6D). In concert with the results obtained in ZR-75-1 cells, expression of MUC1-CD in 3Y1 cells decreased IR-induced chromosomal aberrations (Table 2). These findings indicate that MUC1-CD is sufficient to promote removal of γH2AX foci and attenuate chromosomal aberrations associated with DNA DSBs.

Figure 6. — MUC1-CD is sufficient for promoting γH2AX removal. (A) The indicated 3Y1 cells were left untreated or treated with 2.5 or 10 Gy ionizing radiation (IR) and incubated for 1 h. Lysates were immunoblotted with the indicated antibodies. (B) 3Y1/vector (solid bars) and 3Y1/MUC1-CD-A (open bars) and 3Y1/MUC1-CD-B (shaded bars) cells were treated with 1 Gy IR, incubated for the indicated times, and stained with anti-γH2AX. γH2AX foci were counted for at least 30 cells at each time point. The results are expressed as the relative number (mean ± SD) of γH2AX foci/cell remaining compared to that obtained at 0.25 h. (C) 3Y1/vector (open squares) and 3Y1/MUC1-CD (closed squares) cells were treated with the indicated doses of IR, incubated for 1 h, and analyzed for reactivity with anti-phospho-H3. The results are expressed as the relative number of phospho-H3-positive cells (mean ± SD of 3 experiments) after IR treatment compared to that obtained with unirradiated cells. (D) 3Y1/vector (open squares), 3Y1/MUC1-CD-A (closed squares), and 3Y1/MUC1-CD-B (closed diamonds) cells were treated with 7 Gy IR. The cells were replated at the indicated times. The results are expressed as colony number (mean ± SEM of 3 determinations). SF₂₄/SF₀ for the 3Y1/vector, 3Y1/MUC1-CD-A, and 3Y1/MUC1-CD cells was 1.5, 5.4, and 5.7, respectively.

Table 2.

Chromosome Aberrations in Ionizing Radiation (IR)–Treated 3Y1/Vector and 3Y1/MUC1-CD Cells

	3Y1/Vector		3Y1/MUC1-CD
Aberrations	IR−	IR+	IR−	IR+
Chromosome breaks	0	0	0	0
Chromatid breaks	0	1	0	0
Triradial (tr) and quadriradial	4	3	0	0
Complex radial	0	0	0	0
Dicentric chromosomes	0	0	0	0
Tricentric chromosomes	0	0	0	0
Ring chromosomes	0	4	0	3
Double minutes	4	34	9	8
Acentric fragments	31	278	38	84
Telomeric association (of acrocentric chromosomes)	0	0	0	0
Fission (centrometric, longitudinal)	13	16	0	0
Total # aberrations	52	336	47	95

Open in a new tab

Discussion

MUC1-C interacts directly with ATM

The present work demonstrates that the MUC1-C subunit associates with ATM in cells. The MUC1-C cytoplasmic domain binds directly to ATM HEAT repeats that are downstream to those identified for binding of NBS1. MUC1-C localizes to the nucleus in diverse cell types,^17,29,42,43 associates with transcription factors such as p53, and contributes to the regulation of gene activation.^27,30,44 Other work has shown that MUC1-C blocks death in the response to genotoxic anticancer agents.^31,35 However, to our knowledge, there has been no evidence to support involvement of MUC1-C in responses attributable to ATM function, such as DNA repair, activation of cell cycle checkpoints, or radiosensitivity. Nonetheless, the present results obtained from cells with stable silencing of endogenous MUC1 indicate that the MUC1-C oncoprotein affects levels of H2AX phosphorylation and survival in the response to IR. Similar results were obtained with cells that stably express MUC1-CD, indicating that the MUC1-C cytoplasmic domain is sufficient to mediate these effects. Notably, MUC1 had no apparent effect on IR-induced ATM activation (data not shown), indicating that MUC1-C affects downstream events that are mediated by the ATM-H2AX complex.

MUC1 promotes removal of IR-induced γH2AX foci

DNA DSBs can result in genomic instability if not subjected to adequate detection and repair. H2AX, an important component for optimal repair of these lesions, is phosphorylated on serines to form γH2AX foci at DNA DSB sites.³ In this context, detection of γH2AX is used to assess the extent of initial DNA DSBs, and the rate of removal is employed as an indicator of DNA DSB repair.^3,15 The present studies demonstrate that silencing MUC1 in ZR-75-1 cells is associated with an increased intensity of γH2AX detection after IR treatment. In addition, in cells expressing endogenous MUC1, IR-induced γH2AX levels were substantially decreased by 4 h as compared to persistence of γH2AX at 24 h in the MUC1-silenced cells. The role of MUC1-CD in regulating γH2AX levels was confirmed in the IR response of 3Y1 cells. These results could have been attributable to a role for MUC1 in blocking ATM phosphorylation of H2AX in the response to IR. However, MUC1 had little if any effect on IR-induced activation of ATM and phosphorylation of other substrates, such as Chk2 (data not shown). The findings thus indicate that MUC1 promotes removal of IR-induced γH2AX, perhaps by promoting DNA DSB rejoining and thereby more rapid disappearance of γH2AX. Consistent with this model, MUC1 expression was clearly associated with more rapid kinetics of γH2AX removal following IR exposure. Moreover, survival in response to IR further indicated that MUC1 promotes the kinetics of γH2AX removal through DNA repair.

MUC1 protects against IR-induced cell death

Analysis of chromosomes from irradiated ZR-75-1 cells demonstrated that, in the absence of MUC1, there was an increase in chromatid breaks, double minutes, and fissions. Moreover, there was an increase in chromosome aberrations in irradiated 3Y1/vector cells, as compared to 3Y1/MUC1-CD cells, which were predominantly in the form of acentric fragments. In further support of a MUC1-mediated effect, we irradiated cells, and after 24 h, the cells were seeded and analyzed for clonogenic survival. In this assay, survival rates are greater for cells that are stimulated to grow immediately after irradiation, and the increase in survival corresponds to potentially lethal damage repair (PLDR).^45,46 The results obtained from both ZR-75-1 and 3Y1 cells demonstrate that MUC1 protects against IR-induced death. These findings obtained for cell cycle progression, chromosome aberrations, and survival collectively indicate that MUC1 expression is associated with increased repair of IR-induced DNA lesions. A striking aspect of these findings is that MUC1-C, a cell membrane-associated protein, interacts with the DNA repair machinery. In this regard, NEMO, an activator of the canonical NF-κB pathway and a MUC1-C binding partner,²⁶ associates with death receptors at the cell membrane and interacts with ATM.^47,48 However, the effects of the NEMO-ATM interaction on radiosensitivity are not known.

Why would MUC1 contribute to DNA repair?

MUC1 is a major component of a physical barrier that protects the epithelial cell layer from damage induced by diverse forms of stress, including ROS, which are encountered at the interface with the external environment. In the epithelial stress response, damage induces the disruption of tight junctions, loss of polarity, and activation of a repair and survival program.⁴⁹ The available evidence indicates that MUC1 contributes to this repair and survival program through nuclear targeting of the MUC1-C subunit.^27-29,35 Thus, in the stress response of normal epithelial cells, nuclear MUC1-C could transiently protect against damage-induced DNA lesions. By contrast, with transformation, MUC1-C is constitutively expressed in the nucleus.^27-29,35 Irreversible nuclear targeting of MUC1-C in carcinoma cells could therefore confer a phenotype, as found in ZR-75-1 cells, that constitutively promotes repair of DNA lesions. In this regard, other studies have shown that MUC1 protects against death induced by ROS that, like IR, also induce DNA DSBs.^36-38 Radiotherapy is widely used as a treatment modality for breast cancer; however, for patients who develop recurrence of their disease, the mechanisms responsible for radioresistance are not well understood. MUC1-induced repair of DNA lesions could protect against genomic instability but also contribute to protection of tumors against treatment with IR and other genotoxic anticancer agents. Therefore, human breast tumors that overexpress MUC1 may have a survival advantage to genotoxic stress by exploiting mechanisms that evolved for the repair of damaged epithelia. In that context, recent studies have demonstrated that direct targeting of MUC1-C oligomerization in breast cancer cells blocks nuclear localization of MUC1-C and activates the DNA damage response.⁵⁰ The MUC1-C inhibitor could thus be effective in potentiating the therapeutic response of radiation in the treatment of breast cancers.

Materials and Methods

Cell culture

ZR-75-1/vector and ZR-75-1/MUC1siRNA cells³¹ were grown in RPMI1640 medium containing 10% heat-inactivated fetal bovine serum (HI-FBS), 100 units/mL penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine. 293 embryonal kidney cells, rat 3Y1/vector, and 3Y1/MUC1-CD fibroblasts²⁴ were cultured in Dulbecco’s modified Eagle’s medium with 10% HI-FBS, antibiotics, and L-glutamine. Cells were irradiated at room temperature with a γ-ray source (Cs¹⁷³; Gamma Cell 1000; Atomic Energy of Canada, Ottawa, Canada) at a fixed dose of 0.76 Gy/min.

Immunoprecipitation and immunoblotting

Lysates were immunoprecipitated with anti-MUC1-C (Ab-5; Neomarkers, Fremont, CA), anti-ATM, anti-Myc (Santa Cruz Biotechnology, Santa Cruz, CA), and anti-Flag (M2; Sigma, St. Louis, MO). The precipitates and lysates not subjected to immunoprecipitation were immunoblotted with anti-MUC1-C, anti-ATM, anti-GFP (BD Biosciences Clontech, Palo Alto, CA), anti-ATM-phospho-Ser-1981 (Rockland, Gilbertsville, PA), anti-β-actin (Sigma), and anti-γH2AX and anti-H2AX (Cell Signaling Technology, Beverly, MA). Immunocomplexes were detected with horseradish peroxidase–conjugated secondary antibodies and enhanced chemiluminescence (ECL; Amersham Biosciences, Piscataway, NJ).

In vitro binding assays

GST and GST-ATM fusion proteins bound to glutathione beads were incubated with cell lysates or purified His-MUC1-CD in binding buffer²⁴ for 4 h at 4°C. Adsorbates to the beads were washed 6 times and subjected to immunoblot analysis.

Immunofluorescence

Cells in culture were fixed in 3% paraformaldehyde/phosphate-buffered saline (PBS) for 10 min and permeabilized in 0.5% Triton X-100 for 5 min. Incubations with primary antibody and with Rhodamine Red-X secondary antibody were each performed for 30 min at 37°C. Nuclei were stained with 4′-6-diamidino-2-phenylindole (DAPI). The stained cells were analyzed under a fluorescence microscope.

Flow cytometry

Cells were harvested, washed with PBS, fixed with 80% alcohol, and stained with PI/RNase staining buffer (BD Biosciences PharMingen, San Diego, CA) for 60 min at 4°C in the dark. DNA content was analyzed by flow cytometry.

Cell cycle G2/M arrest assay

Cells seeded in 6-well plates with coverslips were irradiated, incubated for 1 h, fixed, and stained with anti-phospho-histone H3 antibody (Cell Signaling Technology) and DAPI. Cells in mitosis were counted and expressed as a percentage of the control untreated mitotic cell number.

Clonogenic survival assays

Cells were treated with IR, incubated for 24 h, and then plated at 500 to 5000 cells/well in 6-well plates. After 1 to 3 weeks, colonies were stained with crystal violet and counted manually. The surviving fraction was calculated as (number of colonies formed)/(number of cells plated × plating efficiency).

Acknowledgments

The authors thank Dr. M. Kastan for providing the pcDNA3-Flag-ATM plasmid.

Footnotes

Dr. Kharbanda is an employee of Genus Oncology. Dr. Kufe is a founder of Genus Oncology and a consultant to the company. The other authors declare no potential conflicts of interest.

This work was supported by the National Cancer Institute (grant numbers CA97098, CA42802), the National Natural Science Foundation of China (grant numbers 30671169, 30871363), and the Shanghai Pujiang Program (grant number 07pj14065).

References

1. Lavin M, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007;6:931-42 [DOI] [PubMed] [Google Scholar]
2. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001;15:2177-96 [DOI] [PubMed] [Google Scholar]
3. Bonner W, Redon C, Dickey J, Nakamura A, Sedelnikova O, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67 [DOI] [PMC free article] [PubMed] [Google Scholar]
4. Burma S, Chen B, Murphy M, Kurimasa A, Chen D. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001;276:42462-7 [DOI] [PubMed] [Google Scholar]
5. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68 [DOI] [PubMed] [Google Scholar]
6. Kobayashi J, Tauchi H, Sakamoto S, Nakamura A, Morishima K, Matsuura S, et al. NBS1 localizes to γ-H2AX foci through interaction with the FHA/BRCT domain. Curr Biol 2002;12:1846-51 [DOI] [PubMed] [Google Scholar]
7. Tauchi H, Kobayashi J, Morishima K, Matsuura S, Nakamura A, Shiraishi T, et al. The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50/hMRE11/NBS1 complex DNA repair activity. J Biol Chem 2001;276:12-5 [DOI] [PubMed] [Google Scholar]
8. Bassing C, Chua K, Sekiguchi J, Suh H, Whitlow S, Fleming J, et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 2002;99:8173-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
9. Celeste A, Petersen S, Romanienko P, Fernandez-Capetillo O, Chen H, Sedelnikova O, et al. Genomic instability in mice lacking histone H2AX. Science 2002;296:922-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
10. You Z, Chahwan C, Bailis J, Hunter T, Russell P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol Cell Biol 2005;25:5363-79 [DOI] [PMC free article] [PubMed] [Google Scholar]
11. Falck J, Petrini J, Williams B, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 2002;30:290-4 [DOI] [PubMed] [Google Scholar]
12. Gatei M, Young D, Cerosaletti K, Desai-Mehta A, Spring K, Kozlov S, et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. J Biol Chem 2000;279:38813-9 [DOI] [PubMed] [Google Scholar]
13. Girard P, Riballo E, Begg A, Waugh A, Jeggo P. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 2002;21:4191-9 [DOI] [PubMed] [Google Scholar]
14. Yazdi P, Wang Y, Zhao S, Patel N, Lee E, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002;16:571-82 [DOI] [PMC free article] [PubMed] [Google Scholar]
15. Taneja N, Davis M, Choy J, Beckett M, Singh R, Kron S, et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 2004;279:2273-80 [DOI] [PubMed] [Google Scholar]
16. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-32 [DOI] [PubMed] [Google Scholar]
17. Kufe D. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009;9:874-85 [DOI] [PMC free article] [PubMed] [Google Scholar]
18. Merlo G, Siddiqui J, Cropp C, Liscia DS, Lidereau R, Callahan R, et al. DF3 tumor-associated antigen gene is located in a region on chromosome 1q frequently altered in primary human breast cancer. Cancer Res 1989;49:6966-71 [PubMed] [Google Scholar]
19. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 2007;27:992-1004 [DOI] [PMC free article] [PubMed] [Google Scholar]
20. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J Biol Chem 2001;276:6061-4 [DOI] [PubMed] [Google Scholar]
21. Ren J, Li Y, Kufe D. Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J Biol Chem 2002;277:17616-22 [DOI] [PubMed] [Google Scholar]
22. Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol Cell Biol 1998;18:7216-24 [DOI] [PMC free article] [PubMed] [Google Scholar]
23. Raina D, Ahmad R, Kumar S, Ren J, Yoshida K, Kharbanda S, et al. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J 2006;25:3774-83 [DOI] [PMC free article] [PubMed] [Google Scholar]
24. Huang L, Chen D, Liu D, Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein blocks GSK3β-mediated phosphorylation and degradation of β-catenin. Cancer Res 2005;65:10413-22 [DOI] [PubMed] [Google Scholar]
25. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J Biol Chem 1997;272:12492-4 [DOI] [PubMed] [Google Scholar]
26. Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S, et al. MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signaling. Nat Cell Biol 2007;9:1419-27 [DOI] [PMC free article] [PubMed] [Google Scholar]
27. Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005;7:167-78 [DOI] [PubMed] [Google Scholar]
28. Leng Y, Cao C, Ren J, Huang L, Chen D, Ito M, et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J Biol Chem 2007;282:19321-30 [DOI] [PubMed] [Google Scholar]
29. Li Y, Liu D, Chen D, Kharbanda S, Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003;22:6107-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
30. Wei X, Xu H, Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor α. Mol Cell 2006;21:295-305 [DOI] [PubMed] [Google Scholar]
31. Ren J, Agata N, Chen D, Li Y, Yu W-H, Huang L, et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anti-cancer agents. Cancer Cell 2004;5:163-75 [DOI] [PMC free article] [PubMed] [Google Scholar]
32. Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 2006;25:20-31 [DOI] [PubMed] [Google Scholar]
33. Khodarev N, Pitroda S, Beckett M, MacDermed D, Huang L, Kufe D, et al. MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res 2009;69:2833-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
34. Pitroda S, Khodarev N, Beckett M, Kufe D, Weichselbaum R. MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proc Natl Acad Sci USA 2009;106:5837-41 [DOI] [PMC free article] [PubMed] [Google Scholar]
35. Raina D, Kharbanda S, Kufe D. The MUC1 oncoprotein activates the anti-apoptotic PI3K/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 2004;279:20607-12 [DOI] [PubMed] [Google Scholar]
36. Yin L, Huang L, Kufe D. MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 2004;279:45721-7 [DOI] [PubMed] [Google Scholar]
37. Yin L, Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003;278:35458-64 [DOI] [PubMed] [Google Scholar]
38. Yin L, Kharbanda S, Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1 alpha activation in a survival response to hypoxia. J Biol Chem 2007;282:257-66 [DOI] [PubMed] [Google Scholar]
39. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998;20:398-400 [DOI] [PubMed] [Google Scholar]
40. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst) 2004;3:959-67 [DOI] [PubMed] [Google Scholar]
41. Koundrioukoff S, Polo S, Almouzni G. Interplay between chromatin and cell cycle checkpoints in the context of ATR/ATM-dependent checkpoints. DNA Repair (Amst) 2004;3:969-78 [DOI] [PubMed] [Google Scholar]
42. Li Y, Chen W, Ren J, Yu W, Li Q, Yoshida K, et al. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther 2003;2:187-93 [DOI] [PubMed] [Google Scholar]
43. Li Y, Yu W-H, Ren J, Huang L, Kharbanda S, Loda M, et al. Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein. Mol Cancer Res 2003;1:765-75 [PubMed] [Google Scholar]
44. Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007;67:1853-8 [DOI] [PubMed] [Google Scholar]
45. Riballo E, Kühne M, Rief N, Doherty A, Smith G, Recio M, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γH2AX foci. Mol Cell 2004;16:715-24 [DOI] [PubMed] [Google Scholar]
46. Weichselbaum R, Nove J, Little J. Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosum. Nature 1978;271:261-2 [DOI] [PubMed] [Google Scholar]
47. Huang T, Wuerzberger-Davis S, Wu Z, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003;115:565-76 [DOI] [PubMed] [Google Scholar]
48. Wu Z, Shi Y, Tibbetts R, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006;311:1141-6 [DOI] [PubMed] [Google Scholar]
49. Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003;422:322-6 [DOI] [PubMed] [Google Scholar]
50. Ahmad R, Raina D, Joshi MD, Kawano T, Kharbanda S, Kufe D. MUC1-C oncoprotein functions as a direct activator of the NF-kappaB p65 transcription factor. Cancer Res 2009;69:7013-21 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr1-1947601910368059] 1. Lavin M, Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007;6:931-42 [DOI] [PubMed] [Google Scholar]

[bibr2-1947601910368059] 2. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev 2001;15:2177-96 [DOI] [PubMed] [Google Scholar]

[bibr3-1947601910368059] 3. Bonner W, Redon C, Dickey J, Nakamura A, Sedelnikova O, Solier S, et al. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr4-1947601910368059] 4. Burma S, Chen B, Murphy M, Kurimasa A, Chen D. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J Biol Chem 2001;276:42462-7 [DOI] [PubMed] [Google Scholar]

[bibr5-1947601910368059] 5. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68 [DOI] [PubMed] [Google Scholar]

[bibr6-1947601910368059] 6. Kobayashi J, Tauchi H, Sakamoto S, Nakamura A, Morishima K, Matsuura S, et al. NBS1 localizes to γ-H2AX foci through interaction with the FHA/BRCT domain. Curr Biol 2002;12:1846-51 [DOI] [PubMed] [Google Scholar]

[bibr7-1947601910368059] 7. Tauchi H, Kobayashi J, Morishima K, Matsuura S, Nakamura A, Shiraishi T, et al. The forkhead-associated domain of NBS1 is essential for nuclear foci formation after irradiation but not essential for hRAD50/hMRE11/NBS1 complex DNA repair activity. J Biol Chem 2001;276:12-5 [DOI] [PubMed] [Google Scholar]

[bibr8-1947601910368059] 8. Bassing C, Chua K, Sekiguchi J, Suh H, Whitlow S, Fleming J, et al. Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 2002;99:8173-8 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr9-1947601910368059] 9. Celeste A, Petersen S, Romanienko P, Fernandez-Capetillo O, Chen H, Sedelnikova O, et al. Genomic instability in mice lacking histone H2AX. Science 2002;296:922-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr10-1947601910368059] 10. You Z, Chahwan C, Bailis J, Hunter T, Russell P. ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol Cell Biol 2005;25:5363-79 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr11-1947601910368059] 11. Falck J, Petrini J, Williams B, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet 2002;30:290-4 [DOI] [PubMed] [Google Scholar]

[bibr12-1947601910368059] 12. Gatei M, Young D, Cerosaletti K, Desai-Mehta A, Spring K, Kozlov S, et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. J Biol Chem 2000;279:38813-9 [DOI] [PubMed] [Google Scholar]

[bibr13-1947601910368059] 13. Girard P, Riballo E, Begg A, Waugh A, Jeggo P. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene 2002;21:4191-9 [DOI] [PubMed] [Google Scholar]

[bibr14-1947601910368059] 14. Yazdi P, Wang Y, Zhao S, Patel N, Lee E, Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev 2002;16:571-82 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr15-1947601910368059] 15. Taneja N, Davis M, Choy J, Beckett M, Singh R, Kron S, et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 2004;279:2273-80 [DOI] [PubMed] [Google Scholar]

[bibr16-1947601910368059] 16. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 1984;3:223-32 [DOI] [PubMed] [Google Scholar]

[bibr17-1947601910368059] 17. Kufe D. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 2009;9:874-85 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr18-1947601910368059] 18. Merlo G, Siddiqui J, Cropp C, Liscia DS, Lidereau R, Callahan R, et al. DF3 tumor-associated antigen gene is located in a region on chromosome 1q frequently altered in primary human breast cancer. Cancer Res 1989;49:6966-71 [PubMed] [Google Scholar]

[bibr19-1947601910368059] 19. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D. The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 2007;27:992-1004 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr20-1947601910368059] 20. Li Y, Kuwahara H, Ren J, Wen G, Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J Biol Chem 2001;276:6061-4 [DOI] [PubMed] [Google Scholar]

[bibr21-1947601910368059] 21. Ren J, Li Y, Kufe D. Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J Biol Chem 2002;277:17616-22 [DOI] [PubMed] [Google Scholar]

[bibr22-1947601910368059] 22. Li Y, Bharti A, Chen D, Gong J, Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol Cell Biol 1998;18:7216-24 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr23-1947601910368059] 23. Raina D, Ahmad R, Kumar S, Ren J, Yoshida K, Kharbanda S, et al. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J 2006;25:3774-83 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr24-1947601910368059] 24. Huang L, Chen D, Liu D, Yin L, Kharbanda S, Kufe D. MUC1 oncoprotein blocks GSK3β-mediated phosphorylation and degradation of β-catenin. Cancer Res 2005;65:10413-22 [DOI] [PubMed] [Google Scholar]

[bibr25-1947601910368059] 25. Yamamoto M, Bharti A, Li Y, Kufe D. Interaction of the DF3/MUC1 breast carcinoma-associated antigen and β-catenin in cell adhesion. J Biol Chem 1997;272:12492-4 [DOI] [PubMed] [Google Scholar]

[bibr26-1947601910368059] 26. Ahmad R, Raina D, Trivedi V, Ren J, Rajabi H, Kharbanda S, et al. MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signaling. Nat Cell Biol 2007;9:1419-27 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr27-1947601910368059] 27. Wei X, Xu H, Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 2005;7:167-78 [DOI] [PubMed] [Google Scholar]

[bibr28-1947601910368059] 28. Leng Y, Cao C, Ren J, Huang L, Chen D, Ito M, et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. J Biol Chem 2007;282:19321-30 [DOI] [PubMed] [Google Scholar]

[bibr29-1947601910368059] 29. Li Y, Liu D, Chen D, Kharbanda S, Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 2003;22:6107-10 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr30-1947601910368059] 30. Wei X, Xu H, Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor α. Mol Cell 2006;21:295-305 [DOI] [PubMed] [Google Scholar]

[bibr31-1947601910368059] 31. Ren J, Agata N, Chen D, Li Y, Yu W-H, Huang L, et al. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anti-cancer agents. Cancer Cell 2004;5:163-75 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr32-1947601910368059] 32. Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 2006;25:20-31 [DOI] [PubMed] [Google Scholar]

[bibr33-1947601910368059] 33. Khodarev N, Pitroda S, Beckett M, MacDermed D, Huang L, Kufe D, et al. MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. Cancer Res 2009;69:2833-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr34-1947601910368059] 34. Pitroda S, Khodarev N, Beckett M, Kufe D, Weichselbaum R. MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proc Natl Acad Sci USA 2009;106:5837-41 [DOI] [PMC free article] [PubMed] [Google Scholar]

[bibr35-1947601910368059] 35. Raina D, Kharbanda S, Kufe D. The MUC1 oncoprotein activates the anti-apoptotic PI3K/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J Biol Chem 2004;279:20607-12 [DOI] [PubMed] [Google Scholar]

[bibr36-1947601910368059] 36. Yin L, Huang L, Kufe D. MUC1 oncoprotein activates the FOXO3a transcription factor in a survival response to oxidative stress. J Biol Chem 2004;279:45721-7 [DOI] [PubMed] [Google Scholar]

[bibr37-1947601910368059] 37. Yin L, Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 2003;278:35458-64 [DOI] [PubMed] [Google Scholar]

[bibr38-1947601910368059] 38. Yin L, Kharbanda S, Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1 alpha activation in a survival response to hypoxia. J Biol Chem 2007;282:257-66 [DOI] [PubMed] [Google Scholar]

[bibr39-1947601910368059] 39. Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K, et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998;20:398-400 [DOI] [PubMed] [Google Scholar]

[bibr40-1947601910368059] 40. Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst) 2004;3:959-67 [DOI] [PubMed] [Google Scholar]

[bibr41-1947601910368059] 41. Koundrioukoff S, Polo S, Almouzni G. Interplay between chromatin and cell cycle checkpoints in the context of ATR/ATM-dependent checkpoints. DNA Repair (Amst) 2004;3:969-78 [DOI] [PubMed] [Google Scholar]

[bibr42-1947601910368059] 42. Li Y, Chen W, Ren J, Yu W, Li Q, Yoshida K, et al. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther 2003;2:187-93 [DOI] [PubMed] [Google Scholar]

[bibr43-1947601910368059] 43. Li Y, Yu W-H, Ren J, Huang L, Kharbanda S, Loda M, et al. Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein. Mol Cancer Res 2003;1:765-75 [PubMed] [Google Scholar]

[bibr44-1947601910368059] 44. Wei X, Xu H, Kufe D. Human mucin 1 oncoprotein represses transcription of the p53 tumor suppressor gene. Cancer Res 2007;67:1853-8 [DOI] [PubMed] [Google Scholar]

[bibr45-1947601910368059] 45. Riballo E, Kühne M, Rief N, Doherty A, Smith G, Recio M, et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γH2AX foci. Mol Cell 2004;16:715-24 [DOI] [PubMed] [Google Scholar]

[bibr46-1947601910368059] 46. Weichselbaum R, Nove J, Little J. Deficient recovery from potentially lethal radiation damage in ataxia telengiectasia and xeroderma pigmentosum. Nature 1978;271:261-2 [DOI] [PubMed] [Google Scholar]

[bibr47-1947601910368059] 47. Huang T, Wuerzberger-Davis S, Wu Z, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003;115:565-76 [DOI] [PubMed] [Google Scholar]

[bibr48-1947601910368059] 48. Wu Z, Shi Y, Tibbetts R, Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006;311:1141-6 [DOI] [PubMed] [Google Scholar]

[bibr49-1947601910368059] 49. Vermeer PD, Einwalter LA, Moninger TO, Rokhlina T, Kern JA, Zabner J, et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 2003;422:322-6 [DOI] [PubMed] [Google Scholar]

[bibr50-1947601910368059] 50. Ahmad R, Raina D, Joshi MD, Kawano T, Kharbanda S, Kufe D. MUC1-C oncoprotein functions as a direct activator of the NF-kappaB p65 transcription factor. Cancer Res 2009;69:7013-21 [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation

Lei Huang

Xiaodong Liao

Michael Beckett

Yuan Li

Kum Kum Khanna

Zhugang Wang

Surender Kharbanda

Ralph Weichselbaum

Donald Kufe

Abstract

Introduction

Results

MUC1-C associates with ATM

Figure 1.

MUC1-CD binds directly to ATM

Figure 2.

MUC1-C CQC motif is responsible for interactions with ATM and H2AX

Figure 3.

MUC1 regulates ATM-mediated phosphorylation of H2AX

Figure 4.

MUC1 promotes removal of γH2AX foci and attenuates loss of clonogenic survival

Figure 5.

Table 1.

MUC1-CD is sufficient for promoting removal of IR-induced γH2AX foci

Figure 6.

Table 2.

Discussion

MUC1-C interacts directly with ATM

MUC1 promotes removal of IR-induced γH2AX foci

MUC1 protects against IR-induced cell death

Why would MUC1 contribute to DNA repair?

Materials and Methods

Cell culture

Immunoprecipitation and immunoblotting

In vitro binding assays

Immunofluorescence

Flow cytometry

Cell cycle G2/M arrest assay

Clonogenic survival assays

Acknowledgments

Footnotes

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases